Global trends and determinants of HRD and BRCA testing in ovarian cancer management: a cross-sectional study from the european network of young gynaecologic oncologists (ENYGO)
Tibor A. Zwimpfer(University Hospital of Basel), Stamatios Petousis(Aristotle University of Thessaloniki), Zoia Razumova(Karolinska Institutet), Houssein El Hajj(Institut Gustave Roussy), Andrea Rosati(Università Cattolica del Sacro Cuore), Rodrigo Sánchez-Bayona(Research Institute Hospital 12 de Octubre), Aleksandra Strojna(Kliniken Essen-Mitte), Maria Kfoury(Institut Gustave Roussy), Joanna Kacperczyk‐Bartnik(Medical University of Warsaw), Khayal Gasimli(Goethe University Frankfurt), Isabelle Ray-Coquard(Lyon 1 Université), Viola Heinzelmann-Schwarz(University of Basel), Alejandra Martinez(Université Toulouse III - Paul Sabatier), Nicolò Bizzarri(Università Cattolica del Sacro Cuore), Matteo Lambertini(Ospedale Policlinico San Martino), Frédéric Amant(KU Leuven), Esra Bilir(Koç University), İlker Kahramanoğlu(Biruni University), Giuseppe Caruso(European Institute of Oncology), Martina Aida Ángeles(Hospital Sant Joan de Déu Barcelona)
Cited by 0
Related Papers
Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry
|British Journal of Cancer|2017|106
Impact of nerve‐sparing posterolateral parametrial excision for deep infiltrating endometriosis on postoperative bowel, urinary, and sexual function
|International Journal of Gynecology & Obstetrics|2022|83
Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Early Breast Cancer
|JAMA Oncology|2024|77
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer
|Nature Communications|2023|65
Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry
|European Journal of Surgical Oncology|2018|60